1436 related articles for article (PubMed ID: 10539445)
1. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
2. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
[TBL] [Abstract][Full Text] [Related]
3. Prescription drugs: recent trends in utilization, expenditures, and coverage.
Sethi RC
EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
[No Abstract] [Full Text] [Related]
4. Employer drug benefit plans and spending on prescription drugs.
Joyce GF; Escarce JJ; Solomon MD; Goldman DP
JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
[TBL] [Abstract][Full Text] [Related]
5. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
Lillard LA; Rogowski J; Kington R
Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
[TBL] [Abstract][Full Text] [Related]
6. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
LaVange LM; Silverman HA
Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
[TBL] [Abstract][Full Text] [Related]
7. Features of employment-based health plans.
Fronstin P
EBRI Issue Brief; 1998 Sep; (201):1-21. PubMed ID: 10345788
[TBL] [Abstract][Full Text] [Related]
8. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
[TBL] [Abstract][Full Text] [Related]
9. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
Tseng CW; Brook RH; Keeler E; Mangione CM
JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
[TBL] [Abstract][Full Text] [Related]
10. Medicare program; Medicare prescription drug benefit. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
[TBL] [Abstract][Full Text] [Related]
11. Savings needed to fund health insurance and health care expenses in retirement: findings from a simulation model.
Fronstin P; Salisbury D; VanDerhei J
EBRI Issue Brief; 2008 May; (317):1-2, 4-27. PubMed ID: 18630312
[TBL] [Abstract][Full Text] [Related]
12. Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures.
Look KA; Arora P
Res Social Adm Pharm; 2016; 12(5):682-98. PubMed ID: 26632980
[TBL] [Abstract][Full Text] [Related]
13. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
[TBL] [Abstract][Full Text] [Related]
14. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
Morgan SG; Agnew JD; Barer ML
Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
[TBL] [Abstract][Full Text] [Related]
15. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
16. Prescription drug coverage, utilization, and spending among Medicare beneficiaries.
Davis M; Poisal J; Chulis G; Zarabozo C; Cooper B
Health Aff (Millwood); 1999; 18(1):231-43. PubMed ID: 9926660
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in drug use and expenditures in a privately insured population of older adults.
Correa-de-Araujo R; Miller GE; Banthin JS; Trinh Y
J Womens Health (Larchmt); 2005; 14(1):73-81. PubMed ID: 15692281
[TBL] [Abstract][Full Text] [Related]
18. Predictability of prescription drug expenditures for Medicare beneficiaries.
Wrobel MV; Doshi J; Stuart BC; Briesacher B
Health Care Financ Rev; 2003; 25(2):37-46. PubMed ID: 15124376
[TBL] [Abstract][Full Text] [Related]
19. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
[TBL] [Abstract][Full Text] [Related]
20. Health benefits in 2014: stability in premiums and coverage for employer-sponsored plans.
Claxton G; Rae M; Panchal N; Whitmore H; Damico A; Kenward K
Health Aff (Millwood); 2014 Oct; 33(10):1851-60. PubMed ID: 25214470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
